Richard Gayle
Richard Gayle is the founder and president of SpreadingScience, a company focused on leveraging new online technologies in order to increase the rate at which innovation diffuses through an organization. Previously he spent five years as Vice-President, Research and board member (which he still occupies) for Etubics Corporation, a Seattle biotech developing novel vaccines for a range of human diseases.
Richard moved to Seattle in 1986 to join Immunex as a staff scientist, where he worked for 16 years. In addition to his research obligations, which developed technology critical for the company’s research investigations, he was also responsible for the creation and management of the first intranet at Immunex.
After leaving Immunex in 2002, he worked on the Business Development committee of the Washington Biotech and Biomedical Association, which coordinated InvestNW as well as organized several events sponsored by the WBBA. He also currently sits on the board of the Sustainable Path Foundation, which informs the Puget Sound community in areas of sustainability and human health by using scientific understanding and systems thinking. Richard received his BS from the California Institute of Technology and his PhD in biochemistry from Rice University.
Recent posts
Constant facts of all scientific endeavors – Nature always wins. The truth will come out.
An absorbing article last month in The Scientist called The A@#hole Scientist wondered if scientists... Read more »
What happens when a biotech company disappears? We think that the Web remembers everything. Do a search on Wikipedia for Immunex and you get Amgen, with little mention of Immunex at... Read more »
We have many problems in biotechnology but I think Seattle is well positioned to overcome those barriers. Bear with me as I work to one possible approach.
I think there are... Read more »
I lived in Houston when the Oil Bust hit in the 1980s. With it came crushing unemployment. Yet Houston led the nation for the next several years in new business start-ups.... Read more »
And so we embark on a new era of healthcare—one that may take many years to fully reach its potential for good or ill. But there are two small bits in... Read more »
The most incredible things happen when scientists with a common interest have an opportunity to simply talk with one another. On a bone-chilling December night, 50 Seattle researchers from more than... Read more »
Is it still possible to have a long, successful career doing research at a biotech company in the Seattle area? A young scientist today has only a slim chance of working... Read more »
